Cargando…

Environmental factors in autoimmune diseases and their role in multiple sclerosis

An increase in autoimmune diseases poses a socioeconomic challenge worldwide. Predisposing genetic risk has been identified, yet environmental factors make up a significant part of the risk in disease initiation and propagation. Next to improved hygiene and a gross reduction of infections, changes i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jörg, Stefanie, Grohme, Diana A., Erzler, Melanie, Binsfeld, Marilene, Haghikia, Aiden, Müller, Dominik N., Linker, Ralf A., Kleinewietfeld, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097114/ https://www.ncbi.nlm.nih.gov/pubmed/27491297 http://dx.doi.org/10.1007/s00018-016-2311-1

Ejemplares similares

Western lifestyle and immunopathology of multiple sclerosis
por: Matveeva, Olga, et al.
Publicado: (2018)

Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
por: Hammer, Anna, et al.
Publicado: (2017)

Propionic Acid Rescues High-Fat Diet Enhanced Immunopathology in Autoimmunity via Effects on Th17 Responses
por: Haase, Stefanie, et al.
Publicado: (2021)

Multiple sclerosis and nutrition: back to the future?
por: Gold, Ralf, et al.
Publicado: (2020)

The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis
por: Hammer, Anna, et al.
Publicado: (2018)

Inflammation in multiple sclerosis
por: Haase, Stefanie, et al.
Publicado: (2021)

Effects of repetitive twice-weekly transcranial direct current stimulations on fatigue and fatigability in people with multiple sclerosis
por: Linnhoff, Stefanie, et al.
Publicado: (2023)

Peripheral CD19(+) B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
por: Ellrichmann, Gisa, et al.
Publicado: (2018)

Predictors for Therapy Response to Intrathecal Corticosteroid Therapy in Multiple Sclerosis
por: Vohl, Katja, et al.
Publicado: (2019)

Combinations of Susceptibility Genes Are Associated with Higher Risk for Multiple Sclerosis and Imply Disease Course Specificity
por: Akkad, Denis A., et al.
Publicado: (2015)

Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient
por: Wurm, Hannah, et al.
Publicado: (2020)

Propionic acid beneficially modifies osteoporosis biomarkers in patients with multiple sclerosis
por: Duscha, Alexander, et al.
Publicado: (2022)

Structure–Function Relationship of Retinal Ganglion Cells in Multiple Sclerosis
por: Al-Nosairy, Khaldoon O., et al.
Publicado: (2021)

Navigating choice in multiple sclerosis management
por: Linker, Ralf A., et al.
Publicado: (2019)

PARP-1 deregulation in multiple sclerosis
por: Meira, Maria, et al.
Publicado: (2019)

Laquinimod in the treatment of multiple sclerosis: a review of the data so far
por: Thöne, Jan, et al.
Publicado: (2016)

Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells
por: Massa, Megan G., et al.
Publicado: (2016)

Metabolic, Mental and Immunological Effects of Normoxic and Hypoxic Training in Multiple Sclerosis Patients: A Pilot Study
por: Mähler, Anja, et al.
Publicado: (2018)

Metabolic profiles by (1)H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML)
por: Schneider, Ruth, et al.
Publicado: (2017)

Role of Nuclear Factor (Erythroid-Derived 2)-Like 2 Signaling for Effects of Fumaric Acid Esters on Dendritic Cells
por: Hammer, Anna, et al.
Publicado: (2017)

Vascular pathology in multiple sclerosis: mind boosting or myth busting?
por: Waschbisch, Anne, et al.
Publicado: (2011)

Functional and structural readouts for early detection of retinal involvement in multiple sclerosis
por: Al-Nosairy, Khaldoon O., et al.
Publicado: (2023)

Mechanisms of Oxidative Damage in Multiple Sclerosis and Neurodegenerative Diseases: Therapeutic Modulation via Fumaric Acid Esters
por: Lee, De-Hyung, et al.
Publicado: (2012)

Potential of Sodium MRI as a Biomarker for Neurodegeneration and Neuroinflammation in Multiple Sclerosis
por: Huhn, Konstantin, et al.
Publicado: (2019)

CDP-choline to promote remyelination in multiple sclerosis: the need for a clinical trial
por: Gudi, Viktoria, et al.
Publicado: (2023)

CXCR3+ T cells in multiple sclerosis correlate with reduced diversity of the gut microbiome
por: Choileáin, Siobhán Ní, et al.
Publicado: (2019)

Autoimmunity – Multiple Sclerosis
por: Ances, Beau M., et al.
Publicado: (2005)

Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis
por: Selmi, Carlo, et al.
Publicado: (2011)

The therapeutic potential of non-invasive brain stimulation for the treatment of Long-COVID-related cognitive fatigue
por: Linnhoff, Stefanie, et al.
Publicado: (2023)

Cardiac Safety Profile of First Dose of Fingolimod for Relapsing-Remitting Multiple Sclerosis in Real-World Settings: Data from a German Prospective Multi-Center Observational Study
por: Linker, Ralf A., et al.
Publicado: (2016)

Is Multiple Sclerosis an Autoimmune Disease?
por: Wootla, Bharath, et al.
Publicado: (2012)

The Role of Autoimmunity in Multiple Sclerosis
por: Bradl, Monika, et al.
Publicado: (2005)

Multiple Sclerosis and Autoimmune Comorbidities
por: Nociti, Viviana, et al.
Publicado: (2022)

Models of autoimmune demyelination in the central nervous system: on the way to translational medicine
por: Linker, Ralf A, et al.
Publicado: (2009)

Immunometabolic Regulation of Interleukin-17-Producing T Helper Cells: Uncoupling New Targets for Autoimmunity
por: Binger, Katrina J., et al.
Publicado: (2017)

Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab
por: Lee, De-Hyung, et al.
Publicado: (2013)

Proteome Profiling in Murine Models of Multiple Sclerosis: Identification of Stage Specific Markers and Culprits for Tissue Damage
por: Linker, Ralf A., et al.
Publicado: (2009)

Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
por: Wiendl, Heinz, et al.
Publicado: (2021)

Glatiramer Acetate Treatment Normalizes Deregulated microRNA Expression in Relapsing Remitting Multiple Sclerosis
por: Waschbisch, Anne, et al.
Publicado: (2011)

Early remission in multiple sclerosis is linked to altered coherence of the Cerebellar Network
por: Tahedl, Marlene, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e1ru4nnuc0l4jgq1el1se732ek